III
111th CONGRESS
1st Session
S. RES. 324
IN THE SENATE OF THE UNITED STATES
October 27, 2009
Mr. Graham submitted the following resolution; which was considered and agreed to
RESOLUTION
Designating November 1, 2009, as
National Hemangioma Treatment Awareness Day
.
Whereas hemangiomas are the most common benign tumors that occur in infancy;
Whereas hemangiomas appear at birth, or within the first several months of life;
Whereas, each year, approximately 400,000 children in the United States are born with hemangiomas and other vascular anomalies;
Whereas hemangiomas and other vascular anomalies can have a negative effect on the emotional development of a child;
Whereas awareness of the impact of hemangiomas and vascular anomalies on children, their families, and society will lead to improvements in the care of children with hemangiomas;
Whereas the National Institutes of Health supports research on the treatment of, and cure for, hemangiomas and other vascular anomalies;
Whereas The Hemangioma Treatment Foundation has the unique mission of providing treatment to children affected with hemangiomas and other vascular anomalies; and
Whereas The Hemangioma Treatment Foundation is dedicated to finding a cure for hemangiomas and other vascular anomalies: Now, therefore, be it
That the Senate—
designates
November 1, 2009, as National Hemangioma Treatment Awareness
Day
; and
respectfully requests that the Secretary of Senate transmit a copy of this resolution to The Hemangioma Treatment Foundation.